1871 Inhibition of mTOR in combination with chemotherapy and angiogenic blockade shows activity in metaplastic breast cancer, an aggressive, chemo-refractory subtype of triple-negative breast cancer (TNBC)

Autor:	Thorunn Helgason, Filip Janku, Vicente Valero, K. Koenig, Razelle Kurzrock, Vivek Subbiah, Jennifer J. Wheler, Jennifer K. Litton, David S. Hong, Nuhad K. Ibrahim, R. Basho, Daniel D. Karp, M. Gilcrease, Stacy L. Moulder, James L. Murray, Funda Meric-Bernstam, Daniel J. Booser, Constance Albarracin, Mariana Chavez-MacGregor
Rok vydání:	2015
Předmět:	Oncology Cancer Research medicine.medical_specialty Chemotherapy business.industry medicine.medical_treatment medicine.disease Blockade Breast cancer Refractory Internal medicine medicine business PI3K/AKT/mTOR pathway Triple-negative breast cancer
Zdroj:	European Journal of Cancer. 51:S289-S290
ISSN:	0959-8049
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f14b17dc96db6b9951d38a8814511c2c https://doi.org/10.1016/s0959-8049(16)30821-8 Zobrazit plný text záznamu Full Text from ScienceDirect